Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer. (Q43733528)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Jean-Francois Morere

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

P Rebattu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

X Quantin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C Ardiet

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M R Azarian

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M P Schuller-Lebeau

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J L Pujol

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

277-287

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: validation and suitability in phase I clinical trial pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatal pulmonary toxicity resulting from treatment with gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel and interstitial pulmonary injury

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900243-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(00)00243-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11551423%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43733528&oldid=2143383167"